InvestorsHub Logo
Followers 4
Posts 508
Boards Moderated 0
Alias Born 08/02/2005

Re: None

Friday, 02/20/2015 2:03:34 PM

Friday, February 20, 2015 2:03:34 PM

Post# of 2537
I really don't care and this is not for the P&Der"s, but for the poor guy in at much higher levels. This one really wasn't even close and has had a much longer life than it should. What started it?


- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") is pleased to report that up to 6 new breast diagnosis/treatment centres are expected to begin offering BREVAGenplus(R) to their at-risk patients in a systematic broad fashion in the January to March timeframe, with a growing number of additional new breast and imaging centre customers expected to follow later in calendar year 2015.


A rambling almost incoherent sentence filled with so many ambiguities it almost sounds like a SNL script.LOL

Starting with: "up to 6 new breast diagnosis/treatment centres "....what they don't know how many?

"are expected to begin offering BREVAGenplus(R) to their at-risk patients" what? they're not sure LOL

Love this...."to their at-risk patients in a systematic broad fashion" well at least they got the broad's part right.

And the rest is same old stuff.

Good luck and hope you can get out.





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GENE News